More articles Diet and Nutrition



(AFX UK Focus) 2009-03-27 12:13 UPDATE ...
Published:Fri, 27 Mar 2009 12:40:01 GMT
March 27 (Reuters) - Stem cell research firm Osiris Therapeutics Inc said it has stopped enrolling patients in a late-stage trial to test its lead drug candidate, Prochymal, in Cr......
Osiris Discontinues Enrollment in Crohn...
Published:Fri, 27 Mar 2009 11:00:00 GMT
COLUMBIA, Md.----Osiris Therapeutics, Inc. announced today that it has elected to end enrollment at 210 patients in its Phase III trial evaluating Prochymal for Crohn's disease. T......
Crohn's Foundation meeting March 30 (At...
Published:Fri, 27 Mar 2009 00:10:10 GMT
The New Jersey Chapter of the Crohn's & Colitis Foundation of America will hold an education meeting 7-8:30 p.m. March 30 at Jersey Shore Medical Center, Lance Auditorium, 1945 Ro......
Amherstburg natives star in and produce...
Published:Tue, 24 Mar 2009 12:13:08 GMT
WINDSOR — The Powered by Community cycling journey made an indelible mark on the memories of many. Now there is yet another way to raise awareness to Crohn’s and Colitis using......
(AFX UK Focus) 2009-03-27 15:55 UPDATE ...
Published:Fri, 27 Mar 2009 16:24:35 GMT
By Esha Dey......


(AFX UK Focus) 2009-03-27 12:13 UPDATE 1-Osiris stops enrollment in Crohn's disease trial (Interactive Investor)
Published:Fri, 27 Mar 2009 12:40:01 GMT  
March 27 (Reuters) - Stem cell research firm Osiris Therapeutics Inc said it has stopped enrolling patients in a late-stage trial to test its lead drug candidate, Prochymal, in Crohn's disease due to design flaws in the study....

Osiris Discontinues Enrollment in Crohn's Study Due to Concerns with Trial Design (Business Wire via Yahoo! Finance)
Published:Fri, 27 Mar 2009 11:00:00 GMT  
COLUMBIA, Md.----Osiris Therapeutics, Inc. announced today that it has elected to end enrollment at 210 patients in its Phase III trial evaluating Prochymal for Crohn's disease. The Company believes there is a design flaw in the trial resulting in significantly higher than expected placebo response rates....

Crohn's Foundation meeting March 30 (Atlanticville)
Published:Fri, 27 Mar 2009 00:10:10 GMT  
The New Jersey Chapter of the Crohn's & Colitis Foundation of America will hold an education meeting 7-8:30 p.m. March 30 at Jersey Shore Medical Center, Lance Auditorium, 1945 Route 33, Neptune. Penny Turtel, M.D., and Shamina Dhillon, M.D....

Amherstburg natives star in and produce documentary to benefit Crohn's and Colitis Foundation of Canada (The Amherstburg Echo)
Published:Tue, 24 Mar 2009 12:13:08 GMT  
WINDSOR — The Powered by Community cycling journey made an indelible mark on the memories of many. Now there is yet another way to raise awareness to Crohn’s and Colitis using the same memorable journey that Amherstburg natives Greg Mailloux and Vin Heney made.[...]...


Osiris halts trial enrollment, stock falls (Baltimore Business Journal)
Published:Fri, 27 Mar 2009 15:28:28 GMT  
Osiris Therapeutics Inc. has halted enrollment in a final stage trial of its Crohn’s disease drug, triggering a drop in its stock price. (OSIR)...

Research and Markets: Disease and Therapy Review: Crohn's Disease - Available Now (Business Wire via Yahoo! Finance)
Published:Fri, 20 Mar 2009 10:06:00 GMT  
DUBLIN, Ireland----Research and Markets has announced the addition of the Disease and Therapy Review: Crohn's Disease report to their offering....

As a Result of the FDA Investigation Into TNF-Alpha Inhibitors, 30 Percent of Surveyed Rheumatologists Have Altered ... (PR Newswire via Yahoo! Finance)
Published:Thu, 26 Mar 2009 13:20:00 GMT  
alpha Inhibitors for Juvenile Idiopathic Arthritis and Pediatric Crohn's Disease, According to a New Report from Decision Resources...

Osiris Up to Its Old Tricks Again (TheStreet.com)
Published:Fri, 27 Mar 2009 16:18:24 GMT  
A press release regarding the end of a trial of stem-cell drug Prochymal highlights all that's wrong with this company....
© 2012 | Privacy Policy | Powered By Noomle.com | SiteMap